Temporal Trends in the Incidence of and Mortality Associated With Heart Failure With Preserved and Reduced Ejection Fraction
- PMID: 30007560
- PMCID: PMC6076350
- DOI: 10.1016/j.jchf.2018.03.006
Temporal Trends in the Incidence of and Mortality Associated With Heart Failure With Preserved and Reduced Ejection Fraction
Abstract
Objectives: This study aimed to determine temporal trends in the incidence of and mortality associated with heart failure (HF) and its subtypes (heart failure with reduced ejection fraction [HFrEF] and heart rate with preserved ejection fraction [HFpEF]) in the community.
Background: Major shifts in cardiovascular disease risk factor prevalence and advances in therapies may have influenced HF incidence and mortality.
Methods: In the FHS (Framingham Heart Study) and CHS (Cardiovascular Health Study), for participants who were ≥60 years of age and free of HF (n = 15,217; 60% women; 2,524 incident HF cases; 115,703 person-years of follow-up), we estimated adjusted incidence rate ratios of HF, HFrEF, and HFpEF from 1990 to 1999 and 2000 to 2009. We compared the cumulative incidence of and mortality associated with HFrEF versus HFpEF within and between decades.
Results: Across the 2 decades, HF incidence rate ratio was similar (p = 0.13). The incidence rate ratio of HFrEF declined (p = 0.0029), whereas HFpEF increased (p < 0.001). Although HFrEF incidence declined more in men than in women, men had a higher incidence of HFrEF than women in each decade (p < 0.001). The incidence of HFpEF significantly increased over time in both men and women (p < 0.001 and p = 0.02, respectively). During follow-up after HF, 1,701 individuals died (67.4%; HFrEF, n = 557 [33%]; HFpEF, n = 474 [29%]). There were no significant differences in mortality rates (overall, cardiovascular disease, and noncardiovascular disease) across decades within HF subtypes or between HFrEF and HFpEF within decade.
Conclusions: In several U.S. community-based samples from 1990 to 2009, we observed divergent trends of decreasing HFrEF and increasing HFpEF incidence, with stable overall HF incidence and high risk for mortality. Our findings highlight the need to elucidate factors contributing to these observations.
Keywords: ejection fraction; epidemiology; heart failure; incidence; mortality; trends.
Copyright © 2018 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Figures
Comment in
-
Of Probabilities and Uncertainties: Current Challenges of the Heart Failure Epidemic.JACC Heart Fail. 2018 Aug;6(8):686-688. doi: 10.1016/j.jchf.2018.05.003. Epub 2018 Jul 11. JACC Heart Fail. 2018. PMID: 30007552 No abstract available.
Similar articles
-
Sex and Race Differences in Lifetime Risk of Heart Failure With Preserved Ejection Fraction and Heart Failure With Reduced Ejection Fraction.Circulation. 2018 Apr 24;137(17):1814-1823. doi: 10.1161/CIRCULATIONAHA.117.031622. Epub 2018 Jan 19. Circulation. 2018. PMID: 29352072 Free PMC article.
-
Risk Factors and Outcomes Associated With Heart Failure With Preserved and Reduced Ejection Fraction in People With Chronic Kidney Disease.Circ Heart Fail. 2024 May;17(5):e011173. doi: 10.1161/CIRCHEARTFAILURE.123.011173. Epub 2024 May 14. Circ Heart Fail. 2024. PMID: 38742428 Free PMC article.
-
Causes and Temporal Patterns of 30-Day Readmission Among Older Adults Hospitalized With Heart Failure With Preserved or Reduced Ejection Fraction.J Am Heart Assoc. 2018 Apr 23;7(9):e007785. doi: 10.1161/JAHA.117.007785. J Am Heart Assoc. 2018. PMID: 29686028 Free PMC article.
-
Atrial fibrillation and risk of adverse outcomes in heart failure with reduced, mildly reduced, and preserved ejection fraction: A systematic review and meta-analysis.J Cardiovasc Electrophysiol. 2024 Apr;35(4):715-726. doi: 10.1111/jce.16209. Epub 2024 Feb 13. J Cardiovasc Electrophysiol. 2024. PMID: 38348517
-
Epidemiology of heart failure with preserved ejection fraction.Nat Rev Cardiol. 2017 Oct;14(10):591-602. doi: 10.1038/nrcardio.2017.65. Epub 2017 May 11. Nat Rev Cardiol. 2017. PMID: 28492288 Review.
Cited by
-
Non-coding RNAs in the pathophysiology of heart failure with preserved ejection fraction.Front Cardiovasc Med. 2024 Jan 8;10:1300375. doi: 10.3389/fcvm.2023.1300375. eCollection 2023. Front Cardiovasc Med. 2024. PMID: 38259314 Free PMC article. Review.
-
Fibroblast Growth Factor 23 and Exercise Capacity in Heart Failure with Preserved Ejection Fraction.J Card Fail. 2021 Mar;27(3):309-317. doi: 10.1016/j.cardfail.2020.09.477. Epub 2020 Oct 7. J Card Fail. 2021. PMID: 33035687 Free PMC article.
-
Linggui Qihua Decoction Inhibits Atrial Fibrosis by Regulating TGF-β1/Smad2/3 Signal Pathway.Evid Based Complement Alternat Med. 2023 Feb 11;2023:3764316. doi: 10.1155/2023/3764316. eCollection 2023. Evid Based Complement Alternat Med. 2023. PMID: 36820397 Free PMC article.
-
Gut Molecules in Cardiometabolic Diseases: The Mechanisms behind the Story.Int J Mol Sci. 2023 Feb 8;24(4):3385. doi: 10.3390/ijms24043385. Int J Mol Sci. 2023. PMID: 36834796 Free PMC article. Review.
-
Long-Term Outpatient Care and Rehospitalizations in Patients after Cardiac Electrotherapy Device Implantation.Medicina (Kaunas). 2022 Jan 19;58(2):151. doi: 10.3390/medicina58020151. Medicina (Kaunas). 2022. PMID: 35208475 Free PMC article.
References
-
- Go AS, Mozaffarian D, Roger VL, et al. Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation. 2014;129:399–410. - PubMed
-
- Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. The New England journal of medicine. 2006;355:251–9. - PubMed
-
- Kannel WB, Feinleib M, McNamara PM, Garrison RJ, Castelli WP. An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol. 1979;110:281–90. - PubMed
Publication types
MeSH terms
Grants and funding
- N01 HC085080/HL/NHLBI NIH HHS/United States
- U01 HL080295/HL/NHLBI NIH HHS/United States
- N01 HC085082/HL/NHLBI NIH HHS/United States
- N01 HC025195/HL/NHLBI NIH HHS/United States
- N01 HC055222/HL/NHLBI NIH HHS/United States
- N01 HC085079/HL/NHLBI NIH HHS/United States
- K23 HL116780/HL/NHLBI NIH HHS/United States
- R01 AG023629/AG/NIA NIH HHS/United States
- N01 HC085081/HL/NHLBI NIH HHS/United States
- K23 HL118529/HL/NHLBI NIH HHS/United States
- U01 HL130114/HL/NHLBI NIH HHS/United States
- N01 HC085086/HL/NHLBI NIH HHS/United States
- N01 HC085083/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous